Canonical text (the exact bytes fingerprinted)

TRUVACE RECORD VERSION
record: TRV-2026-1156
version: 1
kind: certified
reason: Certified into the record
timestamp: 2026-09-21T06:53:26.163147Z
status: published
lens: g_space
sector: health
headline: Smartphone AI-Enabled Lateral Flow Immunoassay Platform Using Advanced Quantum Dots for Intelligent Quantitative Diagnostics
dek: Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity. Here, we present a smartphone-guided, artificial-intelligence-enhanced LFIA platform that unites a rationally engineered dual-modal nanoprobe with on-device machine learning, demonstrated for quantitative detection of Rift Valley fever virus (RVFV). The platform combines three synergistic princi…
gain_title: Smartphone AI-Enabled Lateral Flow Immunoassay Platform Using Advanced Quantum Dots for Intelligent Quantitative Diagnostics: Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity.
problem_title: (none)
trace_subject: (none)
gain_reading: Smartphone AI-Enabled Lateral Flow Immunoassay Platform Using Advanced Quantum Dots for Intelligent Quantitative Diagnostics: Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity.
gain_evidence: (none)
problem_reading: (none)
problem_evidence: (none)
quick_read: Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity. Here, we present a smartphone-guided, artificial-intelligence-enhanced LFIA platform that unites a rationally engineered dual-modal nanoprobe with on-device machine learning, demonstrated for quantitative detection of Rift Valley fever virus (RVFV).

By coupling dual-modal amplification and magnetic enrichment with AI-driven analysis on widely available hardware, the AQD-LFIA platform offers a scalable route toward next-generation point-of-care and at-home diagnostics.
limitation: 
tag: Evidence-backed gain
key_points: Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity. | Here, we present a smartphone-guided, artificial-intelligence-enhanced LFIA platform that unites a rationally engineered dual-modal nanoprobe with on-device machine learning, demonstrated for quantitative detection of Rift Valley fever virus (RVFV). | The platform combines three synergistic principles: advanced magnetic quantum dot nanoparticles (AQDs) that integrate a magnetic core and a quantum dot shell in a single label to provide both colorimetric and fluorescence signals while enabling magnetic preconcentration of the target antigen; multi-illumination imaging that turns an ordinary smartphone camera into a quantitative reader; and a machine-learning model that extracts illumination-robust features to convert signal into concentration, removing user subjectivity and lighting sensitivity.
rundown: Lateral flow immunoassays (LFIAs) are widely used in point-of-care diagnostics for their low cost and simplicity, but conventional formats rely on subjective visual readout and lack quantitative accuracy and sensitivity. Here, we present a smartphone-guided, artificial-intelligence-enhanced LFIA platform that unites a rationally engineered dual-modal nanoprobe with on-device machine learning, demonstrated for quantitative detection of Rift Valley fever virus (RVFV).

The platform combines three synergistic principles: advanced magnetic quantum dot nanoparticles (AQDs) that integrate a magnetic core and a quantum dot shell in a single label to provide both colorimetric and fluorescence signals while enabling magnetic preconcentration of the target antigen; multi-illumination imaging that turns an ordinary smartphone camera into a quantitative reader; and a machine-learning model that extracts illumination-robust features to convert signal into concentration, removing user subjectivity and lighting sensitivity. This design markedly improves sensitivity over conventional gold-nanosphere LFIA in both modes, enables reliable quantification directly in serum without any pretreatment, and outperforms naked-eye interpretation in blind testing.
sources:
- peer_reviewed | ACS Applied Materials & Interfaces | https://doi.org/10.1021/acsami.6c10769 | 2026-09-21
prev: 0000000000000000000000000000000000000000000000000000000000000000

sha256

d3c3b525ad944e58bc5b58e611d70fd55d2abbddf825008215579083cb839f7a

previous

0000000000000000000000000000000000000000000000000000000000000000